osmin trials. Most studies included patients
with varicose veins (C2), but also with more advanced
CVI, like venous edema (C3), skin changes (C4-C5), venous
ulcers (C6). Pooled data analysis of VADs was given,
although the document also includes breakdown of the
different effect of individual products as well. The number of patients included in many studies was low and the

18

Glov